Comprehensive genetic and epigenetic profiling of maternal uniparental disomy of chromosome 6: insights into the pathogenesis and growth restriction phenotype

Maternal uniparental disomy of chromosome 6 (UPD(6)mat) is an extremely rare condition associated with fetal growth restriction, but its phenotypic spectrum and pathogenesis remain incompletely understood. Through screening of cohorts comprising 309 individuals born small-for-gestational age and 835 patients presenting with Silver–Russell syndrome (SRS)-like features (1,144 in total), we identified four (0.35%) new Japanese patients with UPD(6)mat, who underwent detailed clinical and molecular characterization. Molecular analyses included pyrosequencing, MethylationEPIC array profiling, microsatellite marker analysis, chromosomal microarray analysis, short-read exome sequencing, and Nanopore long-read sequencing for phased, chromosome-wide methylation profiling of chromosome 6. All four patients had severe fetal growth restriction and fulfilled the Netchine–Harbison clinical scoring system criteria for SRS. All were delivered preterm, at 27–29 weeks of gestation, frequently with oligohydramnios and placental underdevelopment. All three male patients had urogenital anomalies, including cryptorchidism and/or hypospadias, and three patients exhibited dysglycemia. Methylation analyses demonstrated hypermethylation at known germline maternally methylated differentially methylated regions (DMRs) on chromosome 6, involving all four DMRs in three patients and three DMRs in one patient, with no evidence of multilocus imprinting disturbance. Microsatellite marker and chromosomal microarray analyses confirmed mixed maternal heterodisomy and isodisomy involving the entire chromosome 6 in three patients and segmental maternal UPD affecting 6q22.3–qter in one patient. Nanopore long-read sequencing confirmed these findings and identified no additional parent-of-origin–dependent methylation differences across chromosome 6. Short-read exome sequencing revealed no pathogenic homozygous variants explaining the shared core phenotype. UPD(6)mat represents a recognizable SRS-like condition characterized by severe pre- and postnatal growth restriction, frequent extreme prematurity, urogenital anomalies, and possible dysglycemia. Epigenetic disturbance appears largely confined to the known germline maternally methylated DMRs on chromosome 6, supporting a model in which imprinting dysregulation, potentially involving loss of paternal PLAGL1 expression, is compounded by placental insufficiency, while recessive allele unmasking may contribute to phenotypic variability.

Authors

Institutions

Publication Details

Journal
Clinical Epigenetics
Published
2026-11-18
DOI
https://doi.org/10.1186/s13148-026-02275-x
Primary Topic
Genetic Syndromes and Imprinting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comprehensive genetic and epigenetic profiling of maternal uniparental disomy of chromosome 6: insights into the pathogenesis and growth restriction phenotype

Masayo Kagami, Reiko Horikawa, Kazuhiko Nakabayashi, Kazuki Yamazawa et al.
3 links
Clinical Epigenetics
Genetic Syndromes and Imprinting
article

Comprehensive genetic and epigenetic profiling of maternal uniparental disomy of chromosome 6: insights into the pathogenesis and growth restriction phenotype

Masayo Kagami, Reiko Horikawa, Kazuhiko Nakabayashi, Kazuki Yamazawa, 久保井 徹, Akie Nakamura, Keiko Matsubara, Ikue Hata, Seiji Mizuno, Tatsuki Urakawa, Kenichiro Hata, Moeko Nakashima
article en

Abstract

Maternal uniparental disomy of chromosome 6 (UPD(6)mat) is an extremely rare condition associated with fetal growth restriction, but its phenotypic spectrum and pathogenesis remain incompletely understood. Through screening of cohorts comprising 309 individuals born small-for-gestational age and 835 patients presenting with Silver–Russell syndrome (SRS)-like features (1,144 in total), we identified four (0.35%) new Japanese patients with UPD(6)mat, who underwent detailed clinical and molecular characterization. Molecular analyses included pyrosequencing, MethylationEPIC array profiling, microsatellite marker analysis, chromosomal microarray analysis, short-read exome sequencing, and Nanopore long-read sequencing for phased, chromosome-wide methylation profiling of chromosome 6. All four patients had severe fetal growth restriction and fulfilled the Netchine–Harbison clinical scoring system criteria for SRS. All were delivered preterm, at 27–29 weeks of gestation, frequently with oligohydramnios and placental underdevelopment. All three male patients had urogenital anomalies, including cryptorchidism and/or hypospadias, and three patients exhibited dysglycemia. Methylation analyses demonstrated hypermethylation at known germline maternally methylated differentially methylated regions (DMRs) on chromosome 6, involving all four DMRs in three patients and three DMRs in one patient, with no evidence of multilocus imprinting disturbance. Microsatellite marker and chromosomal microarray analyses confirmed mixed maternal heterodisomy and isodisomy involving the entire chromosome 6 in three patients and segmental maternal UPD affecting 6q22.3–qter in one patient. Nanopore long-read sequencing confirmed these findings and identified no additional parent-of-origin–dependent methylation differences across chromosome 6. Short-read exome sequencing revealed no pathogenic homozygous variants explaining the shared core phenotype. UPD(6)mat represents a recognizable SRS-like condition characterized by severe pre- and postnatal growth restriction, frequent extreme prematurity, urogenital anomalies, and possible dysglycemia. Epigenetic disturbance appears largely confined to the known germline maternally methylated DMRs on chromosome 6, supporting a model in which imprinting dysregulation, potentially involving loss of paternal PLAGL1 expression, is compounded by placental insufficiency, while recessive allele unmasking may contribute to phenotypic variability.

Clinical Epigenetics
Gunma University (JP), Fukui Prefectural Hospital (JP), Tokyo Medical Center (JP), National Center For Child Health and Development (JP), Shikoku Medical Center for Children and Adults (JP), Aichi Developmental Disability Center (JP), Nagasaki University (JP), National Research Institute for Child Health and Development (JP), Fukui Prefectural University (JP)
Good health and well-being
Genetic Syndromes and Imprinting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon